A new drug target for kidney disease (IMAGE)
Caption
A new study led by ASHBi Professor Motoko Yanagita finds the suppression of two molecules, CD153 and CD30, expressed on immune cells mitigates the progression of kidney disease.
Credit
Kyoto University
Usage Restrictions
None
License
Original content